Brief: GenSight Biologics Announces Approval Of All Resolutions Supported By The Board Of Directors At The Combined General Meeting Of May 13, 2025
May 13 (Reuters) - Gensight Biologics SA SIGHT.PA: GENSIGHT BIOLOGICS ANNOUNCES APPROVAL OF ALL RESOLUTIONS SUPPORTED BY THE BOARD OF DIRECTORS AT THE COMBINED GENERAL MEETING OF MAY 13, 2025 Source text: ID:nBw1k2Mlca Further company coverage: SIGHT.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08